Replies to post #244297 on Biotech Values

[DewDiligence]

PCVX has around $1B(!) in cash:

https://www.globenewswire.com/news-release/2022/11/07/2550261/0/en/Vaxcyte-Reports-Third-Quarter-2022-Financial-Results-and-Provides-Business-Update.html

-- $366.2 Million in Cash, Cash Equivalents and Investments as of September 30, 2022, Excluding Net Proceeds of Approximately $650.7 Million from Recent Public Offering –